Immunogenicity and safety of an inactivated hepatitis a vaccine in anti-HIV positive and negative homosexual men

✍ Scribed by Dr. Georg Hess; Ralf Clemens; Ulrich Bienzle; Christian Schönfeld; Birgit Schunck; Hans-Ludwig Bock

• Publisher: John Wiley and Sons
• Year: 1995
• Tongue: English
• Weight: 394 KB
• Volume: 46
• Category: Article
• ISSN: 0146-6615
• DOI: 10.1002/jmv.1890460109

✦ Synopsis

The immunogenicity, reactogenicity, and safety of an inactivated hepatitis A vaccine were assessed in anti-HIV positive homosexual men. Fourteen anti-HIV positive (group 1) and 20 anti-HIV negative (group 2) men received vaccine (containing 720 ELISA units of hepatitis A antigen per dose) intramuscularly at 0, 1, and 6 months. Twelve unvaccinated anti-HIV positive men (group 3) were included as controls to evaluate disease progression.

Seroconversion (anti-hepatitis V virus (HAW 320 mlU/ml) was higher in group 2 than group 1 at months 2 (100% vs. 73%) and 7 (lOOo/o vs. 77%). Group 2 had higher antibody titres than group 1 at months 1 (201 vs. 92 mlU/ml) and 7 (1,687 vs. 636 mlU/ml). The decline in CD4+ cells between months 0 and 7 was similar in groups 1 and 3 (6.4% vs. 16.2%), showing no evidence for harmful effect of the vaccine on the course of HIV infection. This hepatitis A vaccine appears safe, well tolerated, but less immunogenic in HIV positive homosexual men. o 1995 Wiley-Liss, Inc.